![]() |
|
Revenue Recognition Developments Affect Biopharmaceutical Companies in 2010
Revenue recognition continues to be a point of contention in the biopharmaceutical industry, internally within company management as well as between company management and their auditors. In the bio/pharmaceutical industry, once delivery has occurred or when a price is fixed and determinable, revenue recognition under U.S. GAAP is not so black and white. Click here to view >> Amper, Politziner & Mattia...
We understand that great ideas originate where creativity is encouraged to flourish... Where the entrepreneurial spirit is supported by business professionals who share your vision and pursuit of the innovative edge. Amper’s Life Sciences Practice professionals have the expertise, resources and relationships to assist both public and private life sciences companies bridge the gap between business and science. Our commitment to the industry and the region is evidenced through our active involvement in and support of the BioNJ, New Jersey Technology Council and Pennsylvania Bio. In addition to the traditional tax and accounting services, Amper also assists our Life Sciences clients with services spanning the entire development cycle of companies, including a full range of services, customized for your organization. Contact: John Pennett
|
Contact Us Locations & Directions Site Map Amper, Politziner & Mattia, LLP is now EisnerAmper LLP • 1-866-99-AMPER • info@amper.com |
| web site design and online marketing solutions by Set Now Solutions |